Thanks buildit, everyone here are equally smart. We’re all just trying to learn together. I don’t mean to minimize the minimize the blood assays at all. The Ii-key/SARS/Covid target amino acid sequences from the virus and the ex vitro screening in recovered subjects has been noted by Joe as illustrating a more “complete vaccine.” Also, Joe noted in the last conference cal that the results will help them in Canada to get financial support for the Phase I II and III studies there. That call was only a week or two ago. So I just don’t think Joe is sidestepping anything and when appropriate they’ll provide updates. They were operating on fumes for awhile there which of course slows progress. Hopefully now things are in faster motion and Generex can move the vaccine into full human studies. It’s be nice to see Singapore, China and Sourh Africa bring in licensing fees.